Literature DB >> 17250654

A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines.

Asgar Zaheer1, Smita Zaheer, Shailendra K Sahu, Scott Knight, Houdy Khosravi, Satya N Mathur, Ramon Lim.   

Abstract

The glia maturation factor (GMF), which was discovered in our laboratory, is a highly conserved protein predominantly localized in astrocytes. GMF is an intracellular regulator of stress-related signal transduction. We now report that the overexpression of GMF in astrocytes leads to the destruction of primary oligodendrocytes by interactions between highly purified cultures of astrocytes, microglia, and oligodendrocytes. We infected astrocytes with a replication-defective adenovirus carrying the GMF cDNA. The overexpression of GMF caused the activation of p38 MAP kinase and transcription factor NF-kappaB, as well as the induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA and protein in astrocytes. Small interfering RNA-mediated GMF knockdown completely blocked the GMF-dependent activation of p38 mitogen-activated protein kinase (MAPK), NF-kappaB, and enhanced expression of GM-CSF by astrocytes. Inhibition of p38 MAPK or NF-kappaB by specific inhibitors prevented GM-CSF production. The cell-free conditioned medium from overexpressing GMF astrocytes contained 320 +/- 33 pg/mL of GM-CSF, which was responsible for enhanced production and secretion of TNF-alpha, IL-1beta, IL-6, and IP-10 by microglia. Presence of these inflammatory cytokines in the conditioned medium from microglia efficiently destroyed oligodendrocytes in culture. These results suggest that GMF-induced production of GM-CSF in astrocytes is depending on p38 MAPK and NF-kappaB activation. The GM-CSF-dependent expression and secretion of inflammatory cytokine/chemokine, TNF-alpha, IL-1beta, IL-6, and IP-10, is cytotoxic to oligodendrocytes, the myelin-forming cells in the central nervous system, and as well as neurons. Our results suggest a novel pathway of GMF-initiated cytotoxicity of brain cells, and implicate its involvement in inflammatory diseases such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250654     DOI: 10.1111/j.1471-4159.2006.04385.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

1.  Augmented expression of glia maturation factor in Alzheimer's disease.

Authors:  S Zaheer; R Thangavel; S K Sahu; A Zaheer
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

2.  Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.

Authors:  Asgar Zaheer; Shailendra K Sahu; Yanghong Wu; Ashna Zaheer; Joel Haas; Kiwhoon Lee; Baoli Yang
Journal:  Brain Res       Date:  2007-01-27       Impact factor: 3.252

3.  Molecular Association of Glia Maturation Factor with the Autophagic Machinery in Rat Dopaminergic Neurons: a Role for Endoplasmic Reticulum Stress and MAPK Activation.

Authors:  Govindhasamy Pushpavathi Selvakumar; Shankar S Iyer; Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Ramasamy Thangavel; Iuliia Dubova; Sudhanshu P Raikwar; Smita Zaheer; Asgar Zaheer
Journal:  Mol Neurobiol       Date:  2018-09-14       Impact factor: 5.590

4.  Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord.

Authors:  Smita Zaheer; Yanghong Wu; Xi Yang; Ramasamy Thangavel; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-03-25       Impact factor: 3.996

5.  Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism.

Authors:  Mohammad Moshahid Khan; Smita Zaheer; Ramasamy Thangavel; Margi Patel; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2015-03-10       Impact factor: 3.996

6.  NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.

Authors:  Hayate Javed; Ramasamy Thangavel; Govindhasamy Pushpavathi Selvakumar; Iuliia Dubova; Noah Schwartz; Mohammad Ejaz Ahmed; Smita Zaheer; Duraisamy Kempuraj; Shankar Iyer; Asgar Zaheer; Mohammad Moshahid Khan
Journal:  Int Immunopharmacol       Date:  2020-04-04       Impact factor: 4.932

7.  Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.

Authors:  R Thangavel; D Stolmeier; X Yang; P Anantharam; A Zaheer
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

8.  Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease.

Authors:  Duraisamy Kempuraj; Govindhasamy Pushpavathi Selvakumar; Smita Zaheer; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Sudhanshu Raikwar; Raghav Govindarajan; Shankar Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-26       Impact factor: 4.147

9.  Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Smita Zaheer; Asgar Zaheer
Journal:  J Mol Neurosci       Date:  2014-01-16       Impact factor: 3.444

10.  Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.

Authors:  Maria Manczak; Peizhong Mao; Kazuhiro Nakamura; Christopher Bebbington; Byung Park; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.